These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4628731)

  • 1. Gold excretion correlated with clinical course during chrysotherapy in rheumatoid arthritis.
    Gottlieb NL; Smith PM; Smith EM
    Arthritis Rheum; 1972; 15(6):582-92. PubMed ID: 4628731
    [No Abstract]   [Full Text] [Related]  

  • 2. Intestinal resorption of gold salts used for treatment of rheumatoid arthritis.
    Sairanen E; Vähätalo S
    Scand J Rheumatol; 1973; 2(2):61-4. PubMed ID: 4201507
    [No Abstract]   [Full Text] [Related]  

  • 3. Gold distribution in whole blood during chrysotherapy.
    Smith PM; Smith EM; Gottlieb NL
    J Lab Clin Med; 1973 Dec; 82(6):930-7. PubMed ID: 4202278
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum gold levels during chrysotherapy with relation to urinary and fecal excretion.
    Harth M
    Clin Pharmacol Ther; 1974 Apr; 15(4):354-60. PubMed ID: 4206926
    [No Abstract]   [Full Text] [Related]  

  • 5. Corneal chrysiasis and clinical improvement with chrysotherapy in rheumatoid arthritis.
    Prouse PJ; Kanski JJ; Gumpel JM
    Ann Rheum Dis; 1981 Dec; 40(6):564-6. PubMed ID: 6800311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold kinetics following aurothiomalate therapy: use of a whole-body radiation counter.
    Gerber RC; Paulus HE; Jennrich RI; Lederer M; Bluestone R; Blahd WH; Pearson CM
    J Lab Clin Med; 1974 May; 83(5):778-89. PubMed ID: 4207022
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis.
    Lorber A; Atkins CJ; Chang CC; Lee YB; Starrs J; Bovy RA
    Ann Rheum Dis; 1973 Mar; 32(2):133-9. PubMed ID: 4632661
    [No Abstract]   [Full Text] [Related]  

  • 8. Chrysotherapy in psoriatic arthritis. Efficacy and toxicity compared to rheumatoid arthritis.
    Dorwart BB; Gall EP; Schumacher HR; Krauser RE
    Arthritis Rheum; 1978 Jun; 21(5):513-5. PubMed ID: 96841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chrysotherapy in rheumatoid arthritis with particular emphasis on the effect of chrysotherapy on radiographical changes and on the optimal time of initiation of therapy.
    Luukkainen R
    Scand J Rheumatol Suppl; 1980; 34():1-56. PubMed ID: 6791272
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetics of aurothiomalate in serum and synovial fluid.
    Gerber RC; Paulus HE; Bluestone R; Lederer M
    Arthritis Rheum; 1972; 15(6):625-9. PubMed ID: 4628732
    [No Abstract]   [Full Text] [Related]  

  • 11. Patterns of gold levels in urine, serum, and saliva in patients with rheumatoid arthritis undergoing chrysotherapy.
    Heath MJ; Gillett GT; Swannell AJ; Williams CR; Palmer T
    Ann Rheum Dis; 1987 Nov; 46(11):827-9. PubMed ID: 3122674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term chrysotherapy in rheumatoid arthritis.
    Srinivasan R; Miller BL; Paulus HE
    Arthritis Rheum; 1979 Feb; 22(2):105-10. PubMed ID: 105739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quantitative distribution of gold in skin during chrysotherapy.
    Penneys NS; Kramer K; Gottlieb NL
    J Invest Dermatol; 1975 Sep; 65(3):331-3. PubMed ID: 808577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Continuous chrysotherapy of rheumatoid disease (evaluation of a retrospective study of 42 cases)].
    D'eshougues JR; Delcambre B; Maquerlot M; Defrance D
    Lille Med; 1977; 22(7):430-8. PubMed ID: 412025
    [No Abstract]   [Full Text] [Related]  

  • 15. Postinjection nonvasomotor reactions during chrysotherapy. Constitutional and rheumatic symptoms following injections of gold salts.
    Halla JT; Hardin JG; Linn JE
    Arthritis Rheum; 1977; 20(6):1188-91. PubMed ID: 409414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alveolar macrophage gold retention in rheumatoid arthritis.
    Garcia JG; Munim A; Nugent KM; Bishop M; Hoie-Garcia P; Parhami N; Keogh BA
    J Rheumatol; 1987 Jun; 14(3):435-8. PubMed ID: 3114483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of urinary excretion of gold in patients with rheumatoid arthritis undergoing chrysotherapy.
    Heath MJ; Swannell AJ; Williams CR; Palmer T
    Ann Rheum Dis; 1987 Nov; 46(11):823-6. PubMed ID: 3122673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold therapy.
    Levinson JE; Balz GP; Bondi S
    Arthritis Rheum; 1977 Mar; 20(2 Suppl):531-5. PubMed ID: 122529
    [No Abstract]   [Full Text] [Related]  

  • 19. Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate).
    Jellum E; Munthe E; Guldal G; Aaseth J
    Scand J Rheumatol Suppl; 1979; (28):28-36. PubMed ID: 109914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold compounds in rheumatoid arthritis: clinical-pharmacokinetic correlates.
    Gottlieb NL
    J Rheumatol Suppl; 1979; 5():51-5. PubMed ID: 114649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.